A detailed history of Sara Bay Financial transactions in Abb Vie Inc. stock. As of the latest transaction made, Sara Bay Financial holds 13,382 shares of ABBV stock, worth $2.68 Million. This represents 0.96% of its overall portfolio holdings.

Number of Shares
13,382
Previous 13,790 2.96%
Holding current value
$2.68 Million
Previous $2.37 Billion 11.73%
% of portfolio
0.96%
Previous 0.96%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$163.84 - $199.33 $66,846 - $81,326
-408 Reduced 2.96%
13,382 $2.64 Billion
Q2 2024

Jul 19, 2024

BUY
$154.79 - $180.76 $72,132 - $84,234
466 Added 3.5%
13,790 $2.37 Billion
Q1 2024

Apr 16, 2024

BUY
$159.82 - $182.1 $136,965 - $156,059
857 Added 6.87%
13,324 $2.41 Billion
Q4 2023

Jan 12, 2024

BUY
$137.6 - $154.97 $963 - $1,084
7 Added 0.06%
12,467 $1.93 Billion
Q3 2023

Oct 13, 2023

SELL
$133.59 - $154.65 $16,832 - $19,485
-126 Reduced 1.0%
12,460 $1.86 Billion
Q2 2023

Jul 14, 2023

BUY
$132.51 - $164.9 $11,263 - $14,016
85 Added 0.68%
12,586 $1.7 Billion
Q1 2023

Apr 14, 2023

SELL
$144.61 - $166.54 $124,509 - $143,390
-861 Reduced 6.44%
12,501 $1.99 Billion
Q4 2022

Jan 11, 2023

SELL
$138.31 - $165.87 $7,330 - $8,791
-53 Reduced 0.4%
13,362 $2.16 Billion
Q3 2022

Oct 18, 2022

SELL
$134.21 - $153.93 $11,005 - $12,622
-82 Reduced 0.61%
13,415 $1.8 Billion
Q2 2022

Jul 12, 2022

SELL
$137.62 - $174.96 $3,578 - $4,548
-26 Reduced 0.19%
13,497 $2.08 Billion
Q1 2022

Apr 12, 2022

BUY
$131.98 - $163.75 $64,538 - $80,073
489 Added 3.75%
13,523 $2.19 Billion
Q4 2021

Jan 14, 2022

BUY
$107.43 - $135.93 $281,896 - $356,680
2,624 Added 25.21%
13,034 $1.77 Billion
Q3 2021

Oct 08, 2021

BUY
$106.4 - $120.78 $4,894 - $5,555
46 Added 0.44%
10,410 $1.12 Billion
Q2 2021

Jul 16, 2021

BUY
$105.21 - $117.21 $121,517 - $135,377
1,155 Added 12.54%
10,364 $1.17 Billion
Q1 2021

Apr 14, 2021

BUY
$102.3 - $112.62 $246,645 - $271,526
2,411 Added 35.47%
9,209 $997 Million
Q4 2020

Jan 15, 2021

BUY
$80.49 - $108.67 $144,560 - $195,171
1,796 Added 35.91%
6,798 $728 Million
Q3 2020

Oct 07, 2020

BUY
$85.91 - $100.83 $429,721 - $504,351
5,002 New
5,002 $438 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $354B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Sara Bay Financial Portfolio

Follow Sara Bay Financial and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sara Bay Financial, based on Form 13F filings with the SEC.

News

Stay updated on Sara Bay Financial with notifications on news.